GL

Business Context and Reporting Period

Company: Torchmark Corporation (Note: The filing identifies the registrant as Torchmark Corporation, though the request metadata referenced Globe Life Inc. Torchmark is the parent holding company for Globe Life and Accident Insurance Company and other subsidiaries).

Reporting Period: Fiscal year ended December 31, 2004.

Business Overview: Torchmark is an insurance holding company marketing individual life and supplemental health insurance (including Medicare Supplement, cancer, and hospital-surgical plans) and annuities to middle-income households. Operations are segmented into Life Insurance, Health Insurance, Annuities, and Investments. Distribution channels include direct response, exclusive agencies, independent agencies, and military agencies.

Key Financial Metrics (Year Ended Dec 31, 2004)

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 5% to $3.07 billion, exceeding $3 billion for the first time. Life premium revenue grew 6% to $1.4 billion, while health premium revenue grew 1% to $1.05 billion.
• Profitability: Net income increased 9% ($38.5 million) to $468.6 million. Life insurance segment underwriting margin increased 9% to $352.2 million. Health insurance underwriting margin increased 6% to $174.6 million, driven by improved loss ratios on a closed block of cancer business.
• Investment Environment: Net investment income grew 3%, but growth was constrained by a low interest rate environment. Yields on new investments (6.3%) were lower than the portfolio yield (7.1%).
• Realized Gains: The company reported after-tax realized investment gains of $14.5 million in 2004, compared to losses of $2.2 million in 2003. This included benefits from interest-rate swaps.
• Share Repurchases: Torchmark repurchased 5.5 million shares for $285.2 million in 2004, compared to 5.9 million shares for $225.3 million in 2003.

Guidance, Outlook, Risks, and Unusual Items

Management Commentary and Outlook

• Interest Rates: Management expects mean invested assets to continue growing, but the low interest rate environment will pressure the growth rate of investment income. Strategies to mitigate this include lengthening maturities of new purchases and reducing crediting rates on policy liabilities.
• Health Insurance: Medicare Supplement sales face competitive pressure and regulatory constraints. The company is shifting focus toward other limited-benefit health products (hospital/surgical) which have higher margins and growing demand.
• Life Insurance: Growth is driven by strong sales in the Direct Response and American Income Exclusive Agency channels. The Direct Response unit is the largest U.S. writer of juvenile direct response life insurance.

Risks and Contingencies

• Litigation: Significant exposure to punitive damage claims in Alabama and Mississippi. Approximately 70 active lawsuits were pending as of year-end 2004. A major class action regarding cancer policies (Roberts v. Liberty National Life Insurance Company) was settled in late 2004, requiring premium reductions and benefit adjustments.
• Regulatory: Changes to the federal Medicare program and state-level rate approval delays could impact the Medicare Supplement business.
• Accounting Changes: Adoption of SOP 03-1 regarding guaranteed minimum policy benefits resulted in a one-time after-tax charge of $7.1 million in 2004.

Unusual Items

• Tax Refund: Received a $3.0 million after-tax state income tax refund in 2004 related to a discontinued operation.
• Interest Rate Swaps: GAAP rules require the fair value adjustment of non-hedged derivatives to be reported in realized gains/losses. The benefit from cash settlements on swaps ($23.3 million pretax) was included in realized gains rather than reducing interest expense.

Investor Verification Checklist

• Settlement Terms: Verify the long-term financial impact of the Roberts class action settlement on the closed block of cancer business, specifically the mandated 85% loss ratio and premium reductions.
• Interest Rate Sensitivity: Assess the duration of the fixed-maturity portfolio (average life 12.7 years) against the low-interest rate environment and the potential for reinvestment risk.
• Health Product Mix: Monitor the shift in health premium mix from Medicare Supplement (declining % of total) to other limited-benefit plans to ensure margin sustainability.
• Stock Repurchase Program: Confirm the ongoing authorization and execution of the share repurchase program, which has no defined expiration date or maximum share limit.
• Legal Exposure: Track the status of the approximately 70 active lawsuits in Alabama and Mississippi, particularly those seeking punitive damages.